Clinical Trial Update: Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluated the safety and immunogenicity of PRIMVAC, a placental malaria vaccine candidate, in healthy adults and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PRIMVAC (Placental malaria vaccine candidate)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Malaria | Phase 1 | Status: COMPLETED